Abstract In the last five decades, considerable progress has been made towards understanding the etiology and pathogenesis of periodontal diseases and their interactions with the host. The impact of an individual periodontal condition on systemic homeostasis became more evident because of this knowledge and prompted advances in studies that associate periodontitis with systemic diseases and conditions. The term Periodontal Medicine describes how periodontal infection/inflammation can affect extraoral health. This review presents the current scientific evidence on the most investigated associations between periodontitis and systemic diseases and conditions, such as cardiovascular diseases, diabetes, preterm birth and low birth weight, and pneumonia. Additionally, other associations between periodontitis and chronic inflammatory bowel disease, colorectal cancer, and Alzheimer’s disease that were recently published and are still poorly studied were described. Thus, the aim of this review was to answer the following question: What is the future of Periodontal Medicine? Epidemiological evidence and the evidence of biological plausibility between periodontitis and general health reinforce the rationale that the study of Periodontal Medicine should continue to advance, along with improvements in the epidemiological method, highlighting the statistical power of the studies, the method for data analysis, the case definition of periodontitis, and the type of periodontal therapy to be applied in intervention studies.

Este estudo investigou, histológica e histometricamente, a eficácia da proteína derivada da matriz de esmalte (EMD) associada com vidro bioativo (BG) e membrana absorvível, no tratamento de defeitos de furcas classe III em cães. Após criação cirúrgica e cronificação dos defeitos, as lesões foram divididas aleatoriamente em três grupos de acordo com o tratamento proposto: Grupo Teste 1 - EMD + BG + membrana, Grupo Teste 2 - EMD + membrana e Grupo Controle - BG + membrana. Após 90 dias do período de cicatrização, os cães foram sacrificados. A análise descritiva e os dados histométricos mostraram resultados similares para os grupos experimentais em todos os parâmetros estudados (MANOVA, p > 0,05). As associações de Emdogain com vidro bioativo e RTG, ou somente com RTG, mostraram resultados similares quando comparadas ao vidro bioativo associado à membrana no tratamento de defeito de furca classe III, em cães. As três modalidades de tratamento mostraram preenchimento parcial das furcas com regeneração óssea e cementária limitada à porção apical das mesmas.

This study investigated, both histologically and histometrically, the efficacy of enamel matrix derived proteins (EMD) associated with bioactive glass (BG) and an absorbable membrane in the treatment of class III furcation defects in mongrel dogs. After surgical defect creation and chronification, the lesions were randomly divided into three groups according to the treatment employed: Test Group 1 - EMD + BG + membrane, Test Group 2 - EMD + membrane and Control Group - BG + membrane. After a 90-day healing period, the dogs were sacrificed. The descriptive analysis and the histometric data showed similar results for the experimental groups in all studied parameters (MANOVA, p > 0.05). The association of Emdogain® with bioglass and GTR, or with GTR only, showed similar results when compared with the ones obtained with bioglass associated with membrane in the treatment of class III furcation defects in dogs. The three modalities of treatment showed partial filling of the furcations, with bone and cementum regeneration limited to the apical portion of the defects.